Skip to main content

Table 3 Summary of characteristics in PS and non-PS studies

From: Effect of endoscopic resection on short-term surgical outcomes of subsequent laparoscopic gastrectomy: a meta-analysis

Characteristics

PS/non-PS

Studies

Mean difference (95% CI)

Heterogeneity

Baseline information

 Male

4/5

0.94 [0.65,1.35]; P=0.73/1.83 [1.43, 2.34]; P<0.01

I2=0%; P=0.91/I2=13%; P=0.33

 Age

4/3

2.66 [0.96, 4.36]; P=0.002/6.21 [4.24, 8.19]; P<0.01

I2=25%; P=0.26/I2=57%; P=0.10

 BMI

4/4

−0.13 [−0.60, 0.34]; P=0.58/0.21 [−0.16, 0.58]; P=0.26

I2=0%; P=0.98/I2=38%; P=0.18

 T1-T2

3/4

2.04 [0.40, 10.28]; P=0.39/1.79 [0.30, 10.74]; P=0.53

I2=0%; P=0.49/I2=65%; P=0.04

 T3-T4

3/4

0.49 [0.10, 2.48]; P=0.39/0.56 [0.09, 3.37]; P=0.53

I2=0%; P=0.49/I2=65%; P=0.04

Surgical methods and reconstruction methods

 TG

2/2

1.56 [0.42, 5.88]; P=0.51/0.87 [0.53, 1.44]; P=0.60

I2=0%; P=0.98/I2=0%; P=0.72

 SG

2/2

0.64 [0.17, 2.41]; P=0.51/1.14 [0.72, 1.80]; P=0.58

I2=0%; P=0.98/I2=0%; P=0.73

 B-I or B-II

2/2

0.91 [0.55, 1.52]; P=0.72/1.13[0.31, 4.09]; P=0.85

I2=0%; P=0.84/I2=77%; P=0.04

 Roux-en-Y

2/2

1.10 [0.66, 1.83]; P=0.72/0.96 [0.30, 3.04]; P=0.94

I2=0%; P=0.84/I2=67%; P=0.08

Short-term outcomes

 Blood loss

2/4

12.97 [−60.39, 86.34]; P=0.73/−6.44 [−17.08, 4.20]; P=0.24

I2=91%; P=0.0007/I2=11%; P=0.34

 Operation time

3/4

−5.27 [−13.08, 2.55]; P=0.19/−6.48[−13.02, 0.06]; P=0.05

I2=0%; P=0.39/I2=24%; P=0.27

 Retrieved LNs

3/3

−2.33 [−7.87, 3.21]; P=0.41/−3.14 [−5.01, −1.27]; P=0.001

I2=82%; P=0.004/I2=0%; P=0.70

 Metastatic LNs

4/3

0.96 [0.50, 1.81]; P=0.89/0.52 [0.30, 0.92]; P=0.02

I2=0%; P=0.62/I2=12%; P=0.32

 PHS

2/4

0.60 [−1.25,2.45]; P=0.52/0.53 [−0.37, 1.43]; P=0.25

I2=0%; P=1.00/I2=0%; P=0.95

Postoperative complications

 Overall

4/5

1.25 [0.81, 1.92]; P=0.32/1.11[0.80, 1.54]; P=0.53

I2=0%; P=0.75/I2=15%; P=0.32

 AL

3/4

1.18 [0.22, 6.28]; P=0.84/1.21 [0.49, 2.97]; P=0.68

I2=0%; P=0.77/I2=0%; P=0.45

 AS

2/2

2.27 [0.59, 8.74]; P=0.24/0.86 [0.23, 3.28]; P=0.83

I2=0%; P=0.49/I2=0%; P=0.92

 Ileus

2/5

1.90 [0.45, 8.01]; P=0.38/ 1.66 [0.85, 3.25]; P=0.14

I2=0%; P=0.72/I2=39%; P=0.16

 Abdominal infection

2/3

0.46 [0.05, 4.47]; P=0.50/2.06 [0.87, 4.87]; P=0.10

I2=0%; P=0.76/I2=0%; P=0.61

 Gastric stasis

2/3

0.60 [0.15, 2.36]; P=0.47/0.79 [0.27, 2.28]; P=0.66

I2=0%; P=0.38/I2=0%; P=0.98

 Wound infection

3/3

2.31 [0.78, 6.86]; P=0.13/1.33[0.53, 3.36]; P=0.55

I2=0%; P=0.65/I2=0%; P=0.96

 PL

3/2

2.17 [0.59, 7.97]; P=0.24/0.80 [0.23, 2.77]; P=0.72

I2=0%; P=0.37/I2=9%; P=0.29

 PB

2/2

0.71 [0.18, 2.81]; P=0.63/0.67 [0.12, 3.59]; P=0.64

I2=0%; P=0.96/I2=0%; P=0.91

  1. Abbreviations: ER endoscopic resection, LG laparoscopic gastrectomy, PS propensity score matching, TG total gastrectomy, SG subtotal gastrectomy, LNs lymph nodes, PHS postoperative hospital stay, AL anastomosis leakage, AS anastomotic stenosis, PL pancreatic leakage, PB postoperative bleeding